These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 12237077)

  • 1. Selective mutism and obsessive compulsive disorders associated with zonisamide.
    Hirai K; Kimiya S; Tabata K; Seki T; Jozaki K; Kumagai N
    Seizure; 2002 Oct; 11(7):468-70. PubMed ID: 12237077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of zonisamide monotherapy in a cohort of children with epilepsy.
    Kothare SV; Kaleyias J; Mostofi N; Valencia I; Melvin JJ; Hobdell E; Khurana DS; Legido A
    Pediatr Neurol; 2006 May; 34(5):351-4. PubMed ID: 16647993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zonisamide: a review of its use in the management of partial seizures in epilepsy.
    Frampton JE; Scott LJ
    CNS Drugs; 2005; 19(4):347-67. PubMed ID: 15813651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical experience with zonisamide monotherapy and adjunctive therapy in children with epilepsy at a tertiary care referral center.
    Kim HL; Aldridge J; Rho JM
    J Child Neurol; 2005 Mar; 20(3):212-9. PubMed ID: 15832611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term safety and efficacy of zonisamide versus carbamazepine monotherapy for treatment of partial seizures in adults with newly diagnosed epilepsy: results of a phase III, randomized, double-blind study.
    Baulac M; Patten A; Giorgi L
    Epilepsia; 2014 Oct; 55(10):1534-43. PubMed ID: 25109239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized controlled trial of zonisamide for the treatment of refractory partial-onset seizures.
    Faught E; Ayala R; Montouris GG; Leppik IE;
    Neurology; 2001 Nov; 57(10):1774-9. PubMed ID: 11723262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Open-label, long-term safety study of zonisamide administered to children and adolescents with epilepsy.
    Shinnar S; Pellock JM; Conry JA
    Eur J Paediatr Neurol; 2009 Jan; 13(1):3-9. PubMed ID: 18343174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monotherapy for childhood epilepsies with zonisamide.
    Kumagai N; Seki T; Yamawaki H; Suzuki N; Kimiya S; Yamada T; Hara M; Hashimoto R; Takuma Y; Hirai K
    Jpn J Psychiatry Neurol; 1991 Jun; 45(2):357-9. PubMed ID: 1762217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An assessment of zonisamide as an anti-epileptic drug.
    Jain KK
    Expert Opin Pharmacother; 2000 Sep; 1(6):1245-60. PubMed ID: 11249491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zonisamide-induced behavior disorder in two children.
    Kimura S
    Epilepsia; 1994; 35(2):403-5. PubMed ID: 8156965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Profile of once-daily zonisamide as monotherapy for treatment of partial seizures in adults.
    Mula M
    Drug Des Devel Ther; 2013; 7():397-402. PubMed ID: 23700365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of adjunctive zonisamide treatment on weight and body mass index in children with partial epilepsy.
    Lagae L; Meshram C; Giorgi L; Patten A
    Acta Neurol Scand; 2015 May; 131(5):341-6. PubMed ID: 25659828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zonisamide as a treatment for partial epileptic seizures: a systematic review.
    Cox JH; Seri S; Cavanna AE
    Adv Ther; 2014 Mar; 31(3):276-88. PubMed ID: 24522856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zonisamide: Review of Recent Clinical Evidence for Treatment of Epilepsy.
    Kwan SY; Chuang YC; Huang CW; Chen TC; Jou SB; Dash A
    CNS Neurosci Ther; 2015 Sep; 21(9):683-91. PubMed ID: 26205514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methodological requirements for clinical trials in refractory epilepsies--our experience with zonisamide.
    Yagi K; Seino M
    Prog Neuropsychopharmacol Biol Psychiatry; 1992 Jan; 16(1):79-85. PubMed ID: 1557509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zonisamide for add-on treatment of refractory partial epilepsy: a European double-blind trial.
    Schmidt D; Jacob R; Loiseau P; Deisenhammer E; Klinger D; Despland A; Egli M; Bauer G; Stenzel E; Blankenhorn V
    Epilepsy Res; 1993 May; 15(1):67-73. PubMed ID: 8325280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review of United States and European clinical trials of zonisamide in the treatment of refractory partial-onset seizures.
    Faught E
    Seizure; 2004 Dec; 13 Suppl 1():S59-65; discussion S71-2. PubMed ID: 15511695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Zonisamide as add-on treatment for focal epilepsies. An outcome analysis of 74 patients].
    Wellmer S; Wellmer J; Bauer J
    Nervenarzt; 2008 Dec; 79(12):1416, 1418-23. PubMed ID: 18633587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term effects of zonisamide in the treatment of epilepsy in children with intellectual disability.
    Iinuma K; Minami T; Cho K; Kajii N; Tachi N
    J Intellect Disabil Res; 1998 Dec; 42 Suppl 1():68-73. PubMed ID: 10030436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zonisamide in the management of epilepsy--Japanese experience.
    Ohtahara S
    Epilepsy Res; 2006 Feb; 68 Suppl 2():S25-33. PubMed ID: 16321507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.